ABG Innovation Capital Partners III GP Ltd - Q3 2023 holdings

$736 Thousand is the total value of ABG Innovation Capital Partners III GP Ltd's 3 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 0.0% .

 Value Shares↓ Weighting
CSTL  CASTLE BIOSCIENCES INC$567,943
+23.1%
33,6260.0%77.21%
+22.6%
 AADI BIOSCIENCES INC$129,063
-29.2%
26,6660.0%17.55%
-29.6%
SYBX SellSYNLOGIC INC$38,572
-56.4%
13,727
-93.3%
5.24%
-56.6%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

  • Fan Yu #1
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-11-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
SYNLOGIC INC12Q3 202333.8%
AADI BIOSCIENCES INC9Q3 202337.2%
IDERA PHARMACEUTICALS INC9Q4 20222.4%
GENOCEA BIOSCIENCES INC8Q3 202232.1%
NABRIVA THERAPEUTICS PLC7Q2 20222.3%
CASTLE BIOSCIENCES INC6Q3 202377.2%
PULMONX CORP5Q4 202133.9%
AERPIO PHARMACEUTICALS INC3Q2 20212.3%
ATEA PHARMACEUTICALS INC2Q2 202191.0%
ATEA PHARMACEUTICALS INC1Q1 202180.1%

View ABG Innovation Capital Partners III GP Ltd's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-14
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
13F-HR2023-02-14
13F-HR2022-11-14
13F-HR2022-08-15
13F-HR2022-05-16
13F-HR2022-02-14
13F-HR2021-11-15

View ABG Innovation Capital Partners III GP Ltd's complete filings history.

Compare quarters

Export ABG Innovation Capital Partners III GP Ltd's holdings